Bluu Biosciences

Bluu Biosciences develops marine ingredients through controlled biomanufacturing, producing cell-based seafood using precision fermentation technology. The company has completed the world's first 1000L production run with partner, with next milestone of 2000L in 2027. Bluu's single fish-cell platform powers performance across food, health, and personal care categories without relying on oceans, seasons, or extraction. The company has achieved over 80% cost reduction through process optimization and ongoing media improvements. Founded in 2020 and headquartered in Berlin, Germany, Bluu has raised approximately $25.8M in Series A funding. The company differentiates itself through its proof-based approach with measurable results, credible partner-led scale-up pathway, and regulatory pathway established for cell-based seafood ingredients. Bluu focuses on marine bio-actives for health and personal care, with first-to-market active partner evaluations in premium skincare.